Autoimmune Diseases  >>  CH-4051  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CH-4051 / Lundbeck
MOTION, NCT01116141 / 2010-019134-27: A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)

Completed
2
250
US, Europe, RoW
CH-4051, Methotrexate (MTX), amethopterin, Folic Acid, folate
Chelsea Therapeutics
Rheumatoid Arthritis
04/12
05/12

Download Options